 Market.webp)
Oncology Active Pharmaceutical Ingredient (API) Market size is estimated to surpass USD 7 Billion by the end of 2035, growing at a CAGR of 7% during the forecast period i.e., 2023-2035. In the year 2022, the industry size of oncology active pharmaceutical ingredient (API) was over USD 2 Billion.The growth of the market can be estimated to be the higher prevalence of cancer owing to unhealthy lifestyles and genetic disorders across the globe. Based on the report published by World Health Organization (WHO) it was stated that in 2020, approximately 10 million deaths were caused by cancer around the world. Furthermore, the rising awareness about the effectiveness of active pharmaceutical ingredients (API) on targeted cancerous cells is also anticipated to propel their demand in the upcoming years.
Global oncology active pharmaceutical ingredient (API) market trends such as growing consumption of pain relievers and ongoing multiple Research & Development activities pertaining to the development of novel anti-cancer drugs are further estimated to influence the market growth positively during the forecast period. Other than the aforementioned factors, the recent development by biomarkers to increase the effectiveness of active pharmaceutical ingredients on targeted cancerous cells while minimizing the effect on non-cancerous cells is also anticipated to proliferate the market for growth and expansion. Also, rising awareness among patients regarding the side effects associated with chemotherapy treatments is projected to augment the demand for biologically active drugs with lower dosages coupled with technological advancements to reduce the pain from chronic diseases among patients are other factors that are estimated to bring lucrative growth opportunities for market growth. It is observed that 1 out of 5 individuals which is equivalent to 20 million people in the United States suffers from chronic pain. Thereby, all these factors are projected to fuel the market growth over the forecast period.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~7% |
|
Base Year Market Size (2022) |
~ USD 2 Billion |
|
Forecast Year Market Size (2035) |
~ USD 7 Billion |
|
Regional Scope |
|
Type of Cancer (Breast, Cervical, Lung, Liver, Colorectal)
The global oncology active pharmaceutical ingredient (API) market is segmented and analyzed for demand and supply by type of cancer into breast, cervical, lung, liver, colorectal, and others. Amongst these segments, the breast cancer segment is projected to acquire the largest market share over the forecast period on the back of rising cases of breast cancer. World Health Organization (WHO) showed that in 2020 around 2.26 million cases of breast cancer were diagnosed across the globe. The rising number of deaths owing to breast cancer along with the increased difficulties among patients owing to breast cancer is estimated to increase the demand for oncology active pharmaceutical ingredients in the next few years.
APIs (Innovative Oncology APIs, Generic Oncology APIs)
The global oncology active pharmaceutical ingredient (API) market is also segmented and analyzed for demand and supply by synthesis type into synthetic oncology APIs, and biotech oncology APIs. Out of these two segments, the synthetic oncology APIs segment is anticipated to garner the highest market share owing to the high advantages and benefits offered by them. Low cost for manufacturing synthetic oncology active pharmaceutical ingredients owing to the fewer costs of the raw materials used is considered to be the major factor for segment expansion. Furthermore, the easy process of manufacturing coupled with less complex processes is another factor that is projected to create a positive outlook for segment growth during the analysis period.
Our in-depth analysis of the global market includes the following segments:
|
By APIs |
|
|
By Synthesis Type |
|
|
By Manufacturing Type |
|
|
By Type of Cancer |
|
North American Market Forecast
The North American oncology active pharmaceutical ingredient (API) market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the region is accented to the mounting prevalence of cancer. Data published by the Centers for Disease Control and Prevention showed that in 2019, 1,752,725 new cases of cancer were diagnosed while 599,589 people lost their lives due to cancer in a similar year in the United States. Additionally, the rising geriatric population and developing healthcare infrastructure are further expected to hike the growth of the market over the forecast period. Figures provided by the World Bank showed that in 2021, the number of geriatrics in the USA reached 56,545,938. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies are also anticipated to contribute to the market growth in the region.
APAC Market Statistics
On the other hand, the Asia Pacific oncology active pharmaceutical ingredient (API) is also attributed to garnering a notable market share including a steady CAGR. The presence of a large pool of patients in the region, along with the rising outflow and inflow of patients in the hospitals on a daily basis are projected to be the major factors for market expansion in the region. In addition, the rapid growth in the healthcare industry in the region, especially in China, India, and Japan, and the surge of healthcare expenditure is also anticipated boost market growth during the forecast period.
 Market Size.webp)
AbbVie Inc. conducted a survey, Emotional Impact Report, and released the findings from it. This survey included more than 300 chronic lymphocytic leukemia patients that grow out of blood cancer. The survey also offered mental and emotional support to patients living with slow-growing blood cancer.
Abbott Laboratories to emerge in a study published in the Lancet Neurology to elaborate on the capability of two blood-based biomarkers to predict the results from traumatic brain injury (TBI) and inform treatment interventions.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?